Zheng H - Search Results

1

Establishment of a detection assay for DNA endonuclease activity and its application in the screening and prognosis of malignant lymphoma.

Lu R, Wang Y, Xu X, Xie S, Wang Y, Zhong A, Zheng H, Yu Y, Gao X, Guo L. Lu R, et al. Among authors: zheng h. BMC Biochem. 2018 Jul 31;19(1):6. doi: 10.1186/s12858-018-0096-6. BMC Biochem. 2018. PMID: 30064372 Free PMC article.

2

Inhibition of MUS81 improves the chemical sensitivity of olaparib by regulating MCM2 in epithelial ovarian cancer.

Zhong A, Zhang H, Xie S, Deng M, Zheng H, Wang Y, Chen M, Lu R, Guo L. Zhong A, et al. Among authors: zheng h. Oncol Rep. 2018 Apr;39(4):1747-1756. doi: 10.3892/or.2018.6229. Epub 2018 Jan 22. Oncol Rep. 2018. PMID: 29393493

3

Capable Infection of Hepatitis B Virus in Diffuse Large B-cell Lymphoma.

Wang Y, Wang H, Pan S, Hu T, Shen J, Zheng H, Xie S, Xie Y, Lu R, Guo L. Wang Y, et al. Among authors: zheng h. J Cancer. 2018 Apr 12;9(9):1575-1581. doi: 10.7150/jca.24384. eCollection 2018. J Cancer. 2018. PMID: 29760795 Free PMC article.

4

HE4 as a serum biomarker for ROMA prediction and prognosis of epithelial ovarian cancer.

Chen WT, Gao X, Han XD, Zheng H, Guo L, Lu RQ. Chen WT, et al. Among authors: zheng h. Asian Pac J Cancer Prev. 2014;15(1):101-5. doi: 10.7314/apjcp.2014.15.1.101. Asian Pac J Cancer Prev. 2014. PMID: 24528007 Free article.

5

The NFKB1 polymorphism (rs4648068) is associated with the cell proliferation and motility in gastric cancer.

Chen Y, Lu R, Zheng H, Xiao R, Feng J, Wang H, Gao X, Guo L. Chen Y, et al. Among authors: zheng h. BMC Gastroenterol. 2015 Feb 14;15:21. doi: 10.1186/s12876-015-0243-0. BMC Gastroenterol. 2015. PMID: 25888547 Free PMC article.

6

SIRT7 Exhibits Oncogenic Potential in Human Ovarian Cancer Cells.

Wang HL, Lu RQ, Xie SH, Zheng H, Wen XM, Gao X, Guo L. Wang HL, et al. Among authors: zheng h. Asian Pac J Cancer Prev. 2015;16(8):3573-7. doi: 10.7314/apjcp.2015.16.8.3573. Asian Pac J Cancer Prev. 2015. PMID: 25921180 Free article.

7

MUS81 is associated with cell proliferation and cisplatin sensitivity in serous ovarian cancer.

Xie S, Zheng H, Wen X, Sun J, Wang Y, Gao X, Guo L, Lu R. Xie S, et al. Among authors: zheng h. Biochem Biophys Res Commun. 2016 Aug 5;476(4):493-500. doi: 10.1016/j.bbrc.2016.05.152. Epub 2016 May 30. Biochem Biophys Res Commun. 2016. PMID: 27255997

8

APE1 overexpression promotes the progression of ovarian cancer and serves as a potential therapeutic target.

Wen X, Lu R, Xie S, Zheng H, Wang H, Wang Y, Sun J, Gao X, Guo L. Wen X, et al. Among authors: zheng h. Cancer Biomark. 2016 Sep 26;17(3):313-322. doi: 10.3233/CBM-160643. Cancer Biomark. 2016. PMID: 27802207

9

Targeting TPX2 suppresses proliferation and promotes apoptosis via repression of the PI3k/AKT/P21 signaling pathway and activation of p53 pathway in breast cancer.

Chen M, Zhang H, Zhang G, Zhong A, Ma Q, Kai J, Tong Y, Xie S, Wang Y, Zheng H, Guo L, Lu R. Chen M, et al. Among authors: zheng h. Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):74-82. doi: 10.1016/j.bbrc.2018.10.164. Epub 2018 Nov 16. Biochem Biophys Res Commun. 2018. PMID: 30454896

10

Human leukocyte antigen-E alleles and expression in patients with serous ovarian cancer.

Zheng H, Lu R, Xie S, Wen X, Wang H, Gao X, Guo L. Zheng H, et al. Cancer Sci. 2015 May;106(5):522-8. doi: 10.1111/cas.12641. Epub 2015 Apr 13. Cancer Sci. 2015. PMID: 25711417 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18,207 results

Search Page

Filters